Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Exp Eye Res. 2020 Aug 17;199:108193. doi: 10.1016/j.exer.2020.108193

Figure 2.

Figure 2.

Effect of BF, HEPES, and BR Ringer on Glycolytic Activity in BCEC. A) Lactate production, n=3 per data point, *significantly different from BF, p<0.05. B) Glucose consumption. C) % of Control Lactate production at 2 hours in the presence of 100 μM iodoacetate, n=3 per condition. D) Oxygen Consumption Rate in BF (n=5) vs HEPES (n=6), *p<0.05. E) OCR related to ATP production. F) 2-NBDG uptake in BF, HEPES, and BR, n=3 per condition. No NBDG gate control and 20 μM Glut inhibitor WZB117 control are shown.